BOULDER, Colo., Jan. 11, 2017 -- Boomtown, a startup accelerator that nurtures selected startups through a 12-week mentoring program, is excited to announce that they have established a relationship with the Colorado BioScience Association (CBSA).
As a result of the recently-developed partnership, all Boomtown alumni and teams in health tech will be provided with a 12-month, complimentary membership to CBSA.
“We are incredibly excited to deepen our relationship with CBSA,” said Tom Base, Managing Director, HealthTech at Boomtown. “This is just one of the ways that CBSA and Boomtown continue to collaborate in order to support entrepreneurs in healthcare innovation.”
Colorado BioScience Association serves as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. Representing more than 350 member organizations, CBSA strives to advance the industry throughout the state of Colorado as well as the Rocky Mountain region.
“Startups typically have limited funds to join industry organizations such as ours but are, at the same time, the very ones that would most benefit from our resources,” said April Giles, CBSA CEO. “This partnership provides us access to Boomtown healthcare startups that we can support to hopefully become thriving and viable companies.”
About Boomtown
Based in Boulder, Colo., Boomtown aims to discover and support promising Internet, mobile, software, Internet of Things (IoT) and HealthTech startups. Boomtown is currently launching its seventh Internet and Mobile and third HealthTech classes and has graduated more than 50 companies since founding in 2013. For more information, visit www.boomtownboulder.com.
About Colorado BioScience Association
Colorado BioScience Association champions life science. We serve as the hub of Colorado’s thriving bioscience sector by connecting innovators to funding, infrastructure, research and talent. From promising young companies to established corporations and institutions, we provide opportunities for networking, education and professional development. We grow the bioscience workforce and lead business expansion policies to advance the industry in our state. CBSA represents more than 350 member organizations, including biotechnology, pharmaceutical, medical device, diagnostic, ag bio and mobile digital health companies, research and academic institutions and service providers. Learn more about us at http://www.cobioscience.com.
Contact: Jackie Daane [email protected] 734-277-7006


MATCH Act Targets ASML and Chinese Chipmakers in New U.S. Export Crackdown
Elon Musk Ties SpaceX IPO Access to Mandatory Grok AI Subscriptions
Apple Turns 50: From Garage Startup to AI Crossroads
Jefferies Upgrades Sodexo to Buy With €55 Target After Historic CEO Appointment
Tesla Q1 2026 Deliveries Miss Estimates as AI Strategy Takes Center Stage
Microsoft's $10 Billion Japan Investment: AI Infrastructure and Data Sovereignty Push
UAE's Largest Natural Gas Facility Suspended After Attack-Triggered Fire
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Russell 1000 Companies Hit $2.2T Cash Record While Aggressively Reinvesting in Growth
Nike Beats Q3 Estimates but China Weakness and Margin Pressure Weigh on Outlook
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
Ukrainian Drones and the #MadeByHousewives Movement: Kyiv Fires Back at Rheinmetall CEO
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Star Entertainment Secures $390M Refinancing Deal to Stabilize Operations
Private Credit Under Pressure: Is a Slow-Motion Crisis Unfolding?
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



